Gene · 5587
Papers3,376
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,376
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [CUP syndrome-diagnostics from the perspective of pathology]. | Radiologie (Heidelb) | 2023 | 37079060 | PubTator, text mining | PubMed |
| Cancer Protective Role of Selected Dietary Polyphenols via Modulating Keap1/Nrf2/ARE and Interconnected Signaling Pathways. | Nutr Cancer | 2023 | 37078744 | PubTator, text mining | PubMed |
| COMMD3 loss drives invasive breast cancer growth by modulating copper homeostasis. | J Exp Clin Cancer Res | 2023 | 37072858 | PubTator, text mining | PubMed |
| The mitochondrion of Plasmodium falciparum is required for cellular acetyl-CoA metabolism and protein acetylation. | Proc Natl Acad Sci U S A | 2023 | 37068227 | PubTator, text mining | PubMed |
| The lysophosphatidic acid-regulated signal transduction network in ovarian cancer cells and its role in actomyosin dynamics, cell migration and entosis. | Theranostics | 2023 | 37064875 | PubTator, text mining | PubMed |
| Emerging roles of lysophosphatidic acid receptor subtype 5 (LPAR5) in inflammatory diseases and cancer. | Pharmacol Ther | 2023 | 37061203 | PubTator, text mining | PubMed |
| MicroRNAs expressed during normal wound healing and their associated pathways: A systematic review and bioinformatics analysis. | PLoS One | 2023 | 37053170 | PubTator, text mining | PubMed |
| The biological responses of vitamin K2: A comprehensive review. | Food Sci Nutr | 2023 | 37051359 | PubTator, text mining | PubMed |
| Activin and BMP Signalling in Human Testicular Cancer Cell Lines, and a Role for the Nucleocytoplasmic Transport Protein Importin-5 in Their Crosstalk. | Cells | 2023 | 37048077 | PubTator, text mining | PubMed |
| HDAC Inhibition Restores Response to HER2-Targeted Therapy in Breast Cancer via PHLDA1 Induction. | Int J Mol Sci | 2023 | 37047202 | PubTator, text mining | PubMed |
| The Role of Post-Translational Modifications in Regulation of NLRP3 Inflammasome Activation. | Int J Mol Sci | 2023 | 37047097 | PubTator, text mining | PubMed |
| Golgi-Targeting Anticancer Natural Products. | Cancers (Basel) | 2023 | 37046746 | PubTator, text mining | PubMed |
| PKD phosphorylation and COP9/Signalosome modulate intracellular Spry2 protein stability. | Oncogenesis | 2023 | 37045830 | PubTator, text mining | PubMed |
| Genetic diagnostic yields of 354 Chinese ASD children with rare mutations by a pipeline of genomic tests. | Front Genet | 2023 | 37035742 | PubTator, text mining | PubMed |
| Ferroptosis open a new door for colorectal cancer treatment. | Front Oncol | 2023 | 37007121 | PubTator, text mining | PubMed |
| Prognostic signatures of sphingolipids: Understanding the immune landscape and predictive role in immunotherapy response and outcomes of hepatocellular carcinoma. | Front Immunol | 2023 | 37006285 | PubTator, text mining | PubMed |
| Identification and validation of IgG N-glycosylation biomarkers of esophageal carcinoma. | Front Immunol | 2023 | 36999031 | PubTator, text mining | PubMed |
| Target-driven machine learning-enabled virtual screening (TAME-VS) platform for early-stage hit identification. | Front Mol Biosci | 2023 | 36994428 | PubTator, text mining | PubMed |
| The Drp1-Mediated Mitochondrial Fission Protein Interactome as an Emerging Core Player in Mitochondrial Dynamics and Cardiovascular Disease Therapy. | Int J Mol Sci | 2023 | 36982862 | PubTator, text mining | PubMed |
| Counteracting Colon Cancer by Inhibiting Mitochondrial Respiration and Glycolysis with a Selective PKCδ Activator. | Int J Mol Sci | 2023 | 36982784 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5587/papers?page=14